Pacific Northwest Udall Center (PANUC) Clinical Core
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2012 by University of Washington.
Recruitment status was Recruiting
Information provided by (Responsible Party):
University of Washington
First received: October 31, 2012
Last updated: November 1, 2012
Last verified: October 2012
This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.
||Observational Model: Case-Only
Time Perspective: Prospective
||Pacific Northwest Udall Center (PANUC) Clinical Core
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||July 2014 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Participants fall into either of two categories: A clinical sample (CS) that is evaluated every 2-3 years or an annual sample (AS) that followed once yearly.
All subjects undergo the following procedures:
- History and physical examination
- Questionnaires about mood, activities of daily living, environmental exposures and demographic information.
- Psychometric tests
Study companions may also be asked to complete questionnaires about the study subject regarding medical and psychiatric history, as well as activities of daily living.
- Diagnosis of Parkinson disease
- Over 18 years of age
- Under 18 years of age
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01720810
|VA Puget Sound Health Care System
|Seattle, Washington, United States, 98108 |
|Contact: Emily Ashmore, BS 206-277-3956 email@example.com |
|Principal Investigator: James B Leverenz, M.D. |
University of Washington
No publications provided
||University of Washington
History of Changes
|Other Study ID Numbers:
||UW HSD: 37855
|Study First Received:
||October 31, 2012
||November 1, 2012
||United States: Federal Government
United States: Food and Drug Administration
United States: Institutional Review Board
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 24, 2014
Basal Ganglia Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Nervous System Diseases